Effects of Adding Chickpeas to the American Diet (Long Term Study)
Study Details
Study Description
Brief Summary
This prospective study will assess the effects of adding legumes, especially chick peas, to the diet of healthy adults on the commensal bacteria from feces of human subjects and resulting self-reported GI symptoms as well as markers of immune function.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Long-term observational study:
Subjects enrolled will participate in an observational setting for three months. During this time period, individuals will be encouraged, to maintain increased legume intake and explore new recipes that allow them to maintain a diverse menu of legume based foods. Fecal samples for microbiota analysis will be collected every month. Participants will record a weekly online questionnaire about legume intake and GI health as well as other health status updates. While participants will be encouraged to maintain regular intake of chickpeas throughout the long-term study, consumption of other legumes will be encouraged.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Observational Chickpea Diet Observed long-term to study legume intake and GI health (Observational Chickpea Diet) |
Other: Observational Chickpea Diet
Individuals encouraged to maintain increased legume intake and explore new recipes that allow them to maintain a diverse menu of legume based foods.
Fecal samples collected monthly.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Changes in Number of 16S RNA Sequences on Days 31, Day 62, and Day 93. [Change from Day 31, Day 62, and Day 93]
Compare the gut microbiota composition of individual subjects before and after the implementation of a controlled and observed diet of chickpeas and legume products.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Good Health
-
No systemic antibiotics during the preceding two months
-
No medication suppressing immune function
-
Willingness to provide basic demographic as well as medical history data
Exclusion Criteria:
-
Gastric Ulcers
-
Inflammatory Bowel Disease (IBD) or Irritable Bowel Syndrome (IBS)
-
Chronic constipation/diarrhea
-
Body Mass Index (BMI) > 30
-
Dietary restrictions that prevent legume intake
-
Currently on any medication that can affect GI transit time
-
Consumption of >3 servings/week of chickpeas or >6 servings/week of legumes BEFORE study begins
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Emerging Pathogens Institiute | Gainesville | Florida | United States | 32608 |
Sponsors and Collaborators
- University of Florida
- American Pulse Association
Investigators
- Principal Investigator: Volker Mai, PhD, MPH, Associate Professor
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 201400716 Long Term
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Obersvational Chickpea Diet |
---|---|
Arm/Group Description | Observed long-term to study legume intake and GI health (Observational Chickpea Diet) Observational Chickpea Diet: Individuals encouraged to maintain increased legume intake and explore new recipes that allow them to maintain a diverse menu of legume based foods. Fecal samples collected monthly. |
Period Title: Overall Study | |
STARTED | 12 |
COMPLETED | 1 |
NOT COMPLETED | 11 |
Baseline Characteristics
Arm/Group Title | Obersvational Chickpea Diet |
---|---|
Arm/Group Description | Observed long-term to study legume intake and GI health (Observational Chickpea Diet) Observational Chickpea Diet: Individuals encouraged to maintain increased legume intake and explore new recipes that allow them to maintain a diverse menu of legume based foods. Fecal samples collected monthly. |
Overall Participants | 12 |
Age (Count of Participants) | |
<=18 years |
0
0%
|
Between 18 and 65 years |
12
100%
|
>=65 years |
0
0%
|
Sex: Female, Male (Count of Participants) | |
Female |
7
58.3%
|
Male |
5
41.7%
|
Region of Enrollment (participants) [Number] | |
United States |
12
100%
|
Outcome Measures
Title | Changes in Number of 16S RNA Sequences on Days 31, Day 62, and Day 93. |
---|---|
Description | Compare the gut microbiota composition of individual subjects before and after the implementation of a controlled and observed diet of chickpeas and legume products. |
Time Frame | Change from Day 31, Day 62, and Day 93 |
Outcome Measure Data
Analysis Population Description |
---|
Due to the rate of withdrawal from this study only one participant completed and this data was used for the outcome measures. |
Arm/Group Title | Obersvational Chickpea Diet |
---|---|
Arm/Group Description | Observed long-term to study legume intake and GI health (Observational Chickpea Diet) Observational Chickpea Diet: Individuals encouraged to maintain increased legume intake and explore new recipes that allow them to maintain a diverse menu of legume based foods. Fecal samples collected monthly. |
Measure Participants | 1 |
Day 31 |
49171
|
Day 62 |
48925
|
Day 93 |
49053
|
Adverse Events
Time Frame | 6 months | |
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Obersvational Chickpea Diet | |
Arm/Group Description | Observed long-term to study legume intake and GI health (Observational Chickpea Diet) Observational Chickpea Diet: Individuals encouraged to maintain increased legume intake and explore new recipes that allow them to maintain a diverse menu of legume based foods. Fecal samples collected monthly. | |
All Cause Mortality |
||
Obersvational Chickpea Diet | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
Obersvational Chickpea Diet | ||
Affected / at Risk (%) | # Events | |
Total | 0/12 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Obersvational Chickpea Diet | ||
Affected / at Risk (%) | # Events | |
Total | 0/12 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Volker Mai, PhD, MPH |
---|---|
Organization | University of Florida |
Phone | 352-273-9398 |
vmai@epi.ufl.edu |
- 201400716 Long Term